Insider trade

CEO sold ~$9.92M of EHC shares in the open market

Traded Feb 11, 2026 · Filed Feb 12, 2026

Why it stands out

The boss of Encompass Health sold $9.92M of Encompass Health shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

CEO$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$9,923,082

Shares × reported transaction price

Timing vs results

6 days after results of Feb 5, 2026, 78 days before results of Apr 30, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	−3.3%	+1.1%	−4.4%
30 days	−7.9%	−1.9%	−6.0%
90 days	−2.6%	+9.7%	−12.3%
180 days	+13.3%	+13.3%	0.0%

Past results only. Not a forecast.

This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.58 to $113.52, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within this range.